We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...
AIM 18 December 2020 NOTICE 18/12/2020 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON At the request of the Company the following securities have been cancelled from trading...
Mereo BioPharma Group plc 15 December 2020 Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley Bank...
Mereo BioPharma Group plc 30 November 2020 Mereo BioPharma Reminds Market of Key Dates for AIM Delisting London and Redwood City, Calif., November 30, 2020 - Mereo BioPharma Group plc (NASDAQ:...
The following is a round-up of London-listed company director and manager changes announced on Monday and not separat ...
Mereo BioPharma Group plc 23 November 2020 Mereo BioPharma Appoints Suba Krishnan, M.D. Senior Vice President of Clinical Development London and Redwood City, Calif., November 23, 2020 - Mereo...
Mereo BioPharma Group plc 16 November 2020 Mereo BioPharma to Hold Virtual R&D Day on Tuesday, November 24, 2020 London and Redwood City, Calif., November 16, 2020 - Mereo BioPharma Group plc...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Mereo BioPharma Group plc 11 November 2020 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS...
Mereo BioPharma Group plc 10 November 2020 Mereo BioPharma to Present at the Stifel 2020 Virtual Healthcare Conference London and Redwood City, Calif., November 10, 2020 - Mereo BioPharma Group...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions